Fortune: Big Pharma’s new CEOs must step up to erase inequities in drug access
In this opinion piece for Fortune, Executive Director Jayasree K. Iyer assesses the power of pharmaceutical company CEOs to drive progress in their industry when it comes to access to medicine.
15 December 2020
"I have been asked many times: Does the vision of the CEO have the power to change a pharmaceutical company so it can solve global health challenges?
My answer is “yes.” The power of a top drug industry executive to change the global healthcare landscape is real. On the downside, he or she can cause plenty of damage by adopting the wrong policies. But if they are truly willing to make the radical changes that this industry desperately needs, they can also make a big difference for the good."